πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,465 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7968115

Liposomal curcumin for treatment of cancer

The Board of Regents of the University of Texas System Β· Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7964186

Viruses for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. Β· Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7955596

B. anthracis prevention and treatment: mutant B. anthracis lacking luxs activity and furan

UNIVERSITY OF CONNECTICUT Β· Granted Tue Jun 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7951356

Tissue factor compositions and kits for coagulation and tumor treatment

The Board of Regents of the University of Texas System Β· Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7951543

Methods and compositions for the treatment of psychotic disorders through the identificati

SureGene LLC Β· Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7943318

Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7923004

4-ethynyl pyrazole derivative compounds and methods for treatment of HCV

XTL BIOPHARMACEUTICALS LTD. Β· Granted Tue Apr 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7922999

Administration of growth factors for the treatment of CNS disorders

The Regents of the University of California Β· Granted Tue Apr 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7919246

SEMA4D in cancer diagnosis, detection and treatment

Sagres Discovery, Inc. Β· Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7919496

Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase

Xenon Pharmaceuticals Inc. Β· Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7919088

Treatment and delay of onset of synucleinopathic and amyloidogenic disease

The Regents of the University of California Β· Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7915240

Immunomodulatory compounds and treatment of diseases related to an overproduction of infla

OM PHARMA Β· Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7914780

Aminopeptidase A (APA) targeting peptides for the treatment of cancer

The Board of Regents of the University of Texas System Β· Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7910546

Methods and compositions for the treatment of gastrointestinal disorders

IRONWOOD PHARMACEUTICALS, INC. Β· Granted Tue Mar 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7906555

Aquaporin modulators and methods of using them for the treatment of edema and fluid imbala

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7902241

Ureido substituted benzoic acid compounds and their use for nonsense suppression and the t

PTC THERAPEUTICS, INC. Β· Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7897575

Treatment and prevention of vascular dementia

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7892777

Methods for measuring whether a treatment affects RPTP-ΞΊ activity

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7893027

Treatment of ocular wounds and ulcers

The Board of Regents of the University of Oklahoma Β· Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7879324

Fusion molecules and methods for treatment of immune diseases

The Regents of the University of California Β· Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7879334

Fusion molecules and treatment of IgE-mediated allergic diseases

The Regents of the University of California Β· Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7875598

Compositions useful for the treatment of microbial infections

The Regents of the University of California Β· Granted Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7872110

Deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV

United Biomedical, Inc. Β· Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7867974

Induction of tolerance by oral administration of factor VIII and treatment of hemophilia

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted